Bacterial Infection | MRC Clinical Trials Unit at UCL

Trials on treating drug-resistant TB and other infections.

Antimicrobial resistance to drugs used to treat infections is rising. This means that for some people, standard treatments do not work, and they need to take other drugs, often with more side-effects. Our research includes trials on treating drug resistant TB and other infections.

ARREST

Adjunctive Rifampicin to Reduce Early mortality from STaphylococcus aureus bacteraemia: a multi-centre, randomised, blinded, placebo controlled trial

CDIFF

An International Prospective Observational Study to Assess the Characteristics and Outcomes of Post-transplant Patients Treated for C. Difficile Infections

NeoCHG

Efficacy and safety of whole-body chlorhexidine gluconate (CHG) cleansing in reducing bacterial skin colonisation of hospitalised neonates: A pilot trial

NeoSep1

An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase

Studies in Antimicrobial Resistance

Trials on treating drug-resistant TB and other infections.

Antimicrobial resistance to drugs used to treat infections is rising. This means that for some people, standard treatments do not work, and they need to take other drugs, often with more side-effects. Our research includes trials on treating drug resistant TB and other infections.